ArticleAlzheimer's & dementia (New York, N. Y.)

A splice-switching antisense oligonucleotide targeting APP reduces accumulation of α-synuclein in a mouse model of Parkinson's disease.

Rijwan U Ahammad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.